drugset / Trial / NCT00508118

NICardipine Neuroprotection in AortiC Surgery (NICNACS)

NCT00508118

Phase 2 Terminated 7 enrolled Duke University
RandomizedParallel-groupTriple-blindTreatment

Summary

Objective The objective of this study is to discover whether an infusion of nicardipine is able to reduce the time taken to achieve electrocerebral silence (ECS) during cardiopulmonary bypass (CPB) for aortic surgery. Hypothesis By inhibiting cold-induced cerebral vasoconstriction, nicardipine will maintain cerebral blood flow and allow more rapid cooling of the brain during CPB. This will manifest as a reduction in the time taken to achieve ECS and also as a reduction in overall CPB time.

Timeline

Start
2008-01
Primary completion
2008-04
Completion
2008-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicardipine Small molecule 5 mg